Alphatec Holdings Inc

NEW
STU:L1Z1 (USA)  
€ 8.05 +0.10 (+1.26%) Aug 21
At Loss
Market Cap:
€ 1.25B ($ 1.46B)
Enterprise V:
€ 1.67B ($ 1.95B)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Alphatec Holdings Inc
NAICS : 339112 SIC : 3841
ISIN : US02081G2012

Total Employee Number:

913
Description
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Name Current Vs Industry Vs History
Cash-To-Debt
0.2
Equity-to-Asset
-0.02
Debt-to-Equity
-50.05
Debt-to-EBITDA
28.54
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-0.44
Distress
Grey
Safe
Beneish M-Score
-3.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate
14.5
3-Year EBITDA Growth Rate
53.6
3-Year FCF Growth Rate
71.8
Future 3-5Y Total Revenue Growth Rate Estimate
14.86
Name Current Vs Industry Vs History
5-Day RSI
41.57
9-Day RSI
46.89
14-Day RSI
49.41
3-1 Month Momentum %
3.55
6-1 Month Momentum %
-33.67
12-1 Month Momentum %
-45.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.89
Quick Ratio
1.07
Cash Ratio
0.5
Days Inventory
272.42
Days Sales Outstanding
45.37
Days Payable
71.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-11.7
Shareholder Yield %
-0.75
Name Current Vs Industry Vs History
Gross Margin %
70.84
Operating Margin %
-4.76
Net Margin %
-13.5
EBITDA Margin %
2.6
FCF Margin %
-0.72
OCF Margin %
6.93
ROE %
-1815.92
ROA %
-13.89
ROIC %
-7.74
3-Year ROIIC %
38.24
ROC (Joel Greenblatt) %
-19.43
ROCE %
-10.61
Moat Score
5
Tariff Resilience Score
6

Alphatec Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Alphatec Holdings Inc Stock Events

Financials Calendars
Event Date Price (€)
Fourth quarter earnings conference call for 2026 2027-02-24 16:30 In 185 days
Annual report for 2026 2027-02-24 In 184 days
Fourth quarter earnings results for 2026 2027-02-24 In 184 days
Third quarter earnings conference call for 2026 2026-10-30 16:30 In 68 days
Third quarter earnings results for 2026 2026-10-30 In 67 days
Guidance call for 2026 2026-09-09 15:45 In 17 days
the 19th Annual Piper Sandler MedTech and Diagnostics California Bus Tour 2026-08-19 09:45 8.25 (+3.13%)
Second quarter earnings conference call for 2026 2026-08-04 16:30 8.25 (+1.23%)
Second quarter earnings results for 2026 2026-08-04 8.25 (+1.23%)
General meeting for 2026 2026-06-10 10:00 7.10 (+4.41%)
Show
Entries

Articles on Alphatec Holdings Inc

No articles.